3-D Matrix boosts its presence in the European market with a full calendar of GI events

The event season for 3-D Matrix is in full swing. Kicking off the series of events this autumn, it...

Endoscopic retrograde cholangiopancreatography - PuraStat for effective management of post endoscopic sphincterotomy oozing bleeding: a case series

Endoscopic sphincterotomy (EST) is frequently performed during endoscopic retrograde...

First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)

The use of Transoral Robotic surgery (TORS) is increasingly growing in Head and Neck and in Ear,...

PuraStat shows its efficacy in achieving endoscopic haemostasis in postoperative anastomotic ulcers

A new interesting case report highlights the efficacy of PuraStat for achieving endoscopic...

3-D Matrix Summer Update

3-D Matrix would like to wish you all a wonderful summer and take this opportunity to remind you...

3-D Matrix strengthens its relationship with its distribution partners.

During 3-D Matrix's quarterly European sales meeting, held in Barcelona from the 22nd to the 24th...

Notice regarding the Conclusion of an Agreement Concerning Manufacturing License with FUSO Pharmaceutical Industries, Ltd.

3-D Matrix, Ltd. (headquarters: Chiyoda-ku, Tokyo; President and Representative Director: Jun...

3-D Matrix keeps aiming in the ENT and Plastic Surgery medical areas with PuraBond

The 3-D Matrix agenda keeps being filled with a selection of events, including those dedicated to...

First clinical data demonstrating PuraStat’s safety and efficacy for haemostasis in thyroidectomy and parathyroidectomy. A case series of 353 patients.

Cervical endocrine surgeries such as thyroidectomy and parathyroidectomy can carry the risk of...

US Notice Regarding Marketing Approval for Radiation Proctitis Wound Healing Material

We are pleased to announce that the 510K submitted to the United States Food and Drug...